IFNAR2 (Gene)

Synonyms:ENTREZ:3455, HGNC:5433, IFN-R, IFN-alpha-REC, IFNABR, IFNAR2, IFNARB, IMD45, MIM:602376, NM_000874, NM_001289125, NM_001289126, NM_001289128, NM_001385054, NM_001385055, NM_207584, NM_207585, NP_000865, NP_001276054, NP_001276055, NP_001276057, NP_001371983, NP_001371984, NP_997467, NP_997468, interferon alpha and beta receptor subunit 2
Omim:OMIM:602376
Id:64ebdcc5-a480-52a2-9d96-df96bebf17ac
Hgnc:HGNC:5433
Entrez:3455
Description:interferon alpha and beta receptor subunit 2
The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View IFNAR2's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with IFNAR2.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using IFNAR2.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for IFNAR2.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with IFNAR2.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.